(RTTNews) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):
-Earnings: -$219.48 million in Q2 vs. -$163.56 million in the same period last year. -EPS: -$2.02 in Q2 vs. -$1.63 in the same period last year. -Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$198.30 million or -$1.83 per share for the period. -Analysts projected -$1.86 per share -Revenue: $44.71 million in Q2 vs. $29.91 million in the same period last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.